First-Line Drug Treatment for PSVT in Emergency
Adenosine is the first drug of choice for treating paroxysmal supraventricular tachycardia (PSVT) in an emergency setting, with an initial dose of 6 mg given as a rapid IV bolus followed by a 20 mL saline flush. 1
Treatment Algorithm for PSVT
Initial Assessment and Stabilization
- For hemodynamically unstable patients with PSVT, synchronized cardioversion is recommended 1
- For hemodynamically stable patients, proceed with pharmacological management 1
First-Line Pharmacological Treatment
- Step 1: Attempt vagal maneuvers (Valsalva maneuver or carotid sinus massage) 1, 2
- Step 2: If vagal maneuvers fail, administer adenosine:
Administration Technique for Adenosine
- Use the largest accessible vein, preferably antecubital 1
- Administer as a rapid IV push followed immediately by saline flush 1, 4
- Continuous ECG monitoring is required during administration 1
Second-Line Treatment Options
If adenosine fails or is contraindicated:
Important Considerations and Precautions
Adenosine Contraindications
- Second or third-degree AV block (unless patient has functioning pacemaker) 5
- Sick sinus syndrome or symptomatic bradycardia 5
- Bronchoconstrictive or bronchospastic lung disease (e.g., asthma) 1, 5
- Known hypersensitivity to adenosine 5
Dosage Adjustments
- Reduce initial dose to 3 mg in patients:
- Taking dipyridamole or carbamazepine
- With transplanted hearts
- When administered via central venous access 1
- Larger doses may be required for patients with significant blood levels of theophylline, caffeine, or theobromine 1
Common Side Effects
- Side effects are common but transient and include flushing, dyspnea, and chest discomfort 1, 6
- A defibrillator should be immediately available during administration 1
- Adenosine may induce atrial fibrillation with rapid ventricular rates in patients with Wolff-Parkinson-White syndrome 1
Efficacy
- Adenosine successfully converts 80-90% of PSVT cases 6, 3
- Approximately 70% of patients convert with the initial 6 mg dose 3, 7
- If adenosine fails, calcium channel blockers have conversion success rates of 64-98% 1